| View |
|
DRP-5427-09
|
Cetirizine Hydrochloride
|
CetiCure
|
10 mg
|
Tablet
|
Antihistamine
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
28 August 2024
|
08 August 2029
|
| View |
|
DRP-5485-04
|
Etoricoxib
|
Etorigen
|
120 mg
|
Film-Coated Tablet
|
Selective COX-2 Inhibitor
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
25 August 2024
|
27 August 2029
|
| View |
|
DRP-5723-13
|
Dobutamine (as Hydrochloride)
|
Dobuzef
|
50 mg/mL (250 mg/ 5 mL)
|
Solution for Injection (IV Infusion)
|
Adrenergic Agent
|
Myungmoon Pharmaceutical Co., Ltd.
|
Korea
|
CLIDP Conversion
|
23 August 2024
|
18 July 2028
|
| View |
|
DRP-5789-01
|
Albendazole
|
Pardaz
|
400 mg
|
Chewable Tablet
|
Anthelmintic
|
Medico Remedies Limited
|
India
|
CLIDP Conversion
|
20 August 2024
|
11 November 2029
|
| View |
|
DRP-5932-04
|
Clarithromycin
|
Klarifer
|
125 mg / 5 mL
|
Granules for Oral Suspension
|
Antibacterial (Macrolide)
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
04 September 2024
|
21 February 2027
|
| View |
|
DRP-6140-01
|
Acetylcysteine
|
Actyl
|
100 mg / 5 mL
|
Syrup
|
Mucolytic
|
Norris Medicines Limited
|
India
|
CLIDP Conversion
|
08 September 2024
|
12 May 2025
|
| View |
|
DRP-6176-02
|
Telmisartan
|
Telmiget
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Hizon Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
04 September 2024
|
23 January 2030
|
| View |
|
DRP-6339-06
|
Atorvastatin (as Calcium)
|
Vastamel
|
40 mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
04 September 2024
|
11 September 2025
|
| View |
|
DRP-6340-06
|
Atorvastatin (as calcium)
|
Vastamel
|
20 mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Azarias Pharmaceutical Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
23 August 2024
|
11 September 2025
|
| View |
|
DRP-6341-06
|
Atorvastatin (as Calcium)
|
Vastamel
|
80 mg
|
Film-Coated Tablet
|
HMG CoA Reductase Inhibitor
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
23 August 2024
|
11 September 2025
|
| View |
|
DRP-6364-01
|
Telmisartan
|
None
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
04 September 2024
|
02 October 2025
|
| View |
|
DRP-6378-08
|
Omeprazole
|
None
|
40 mg
|
Capsule
|
Proton Pump Inhibitor
|
Lloyd Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
04 September 2024
|
23 September 2028
|
| View |
|
DRP-6515-02
|
Ascorbic Acid + Zinc
|
Selgaezinc
|
140 mg (equivalent to 157.48 mg Sodium Ascorbate) + 9 mg (equivalent to Zinc Gluconate 62.72 mg) per 5 mL
|
Syrup
|
Vitamin + Mineral
|
J.M. Tolmann Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
04 September 2024
|
09 July 2028
|
| View |
|
DRP-6713-07
|
Fenofibrate
|
Fibranex
|
160 mg
|
Film-Coated Tablet
|
Lipid Modifying Agent (Fibrate)
|
Ravian Life Science Pvt. Ltd
|
India
|
CLIDP Conversion
|
08 September 2024
|
06 June 2026
|
| View |
|
DRP-6729-05
|
Risperidone
|
None
|
2 mg
|
Tablet
|
Antipsychotic
|
LifeSquare Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
20 August 2024
|
20 June 2029
|
| View |
|
DRP-6729-06
|
Risperidone
|
None
|
2 mg
|
Tablet
|
Antipsychotic
|
LifeSquare Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
20 August 2024
|
20 June 2029
|
| View |
|
DRP-7664-01
|
Betamethasone (as Valerate) + Gentamicin (as Sulfate) + Tolnaftate + Clioquinol
|
Quadrovic
|
500 mcg/1 mg/10 mg/10 mg per gram
|
Ointment
|
Anti-Inflammatory/Antipruritic/Antibacterial/Antifungal
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
04 September 2024
|
26 August 2029
|
| View |
|
DRP-8374-08
|
Propofol
|
Aefol
|
10 mg / mL (1 % w/v)
|
Emulsion for Intravenous Infusion
|
General Anesthetic
|
Guangdong Jiabo Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
04 September 2024
|
17 September 2029
|
| View |
|
DRP-8474-03
|
Oxytocin
|
Oxypro
|
10 I.U./ mL
|
Solution for Injection (I.M./I.V.)
|
Oxytocic (Uterine Stimulant)
|
Ma’anshan BBCA Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
04 September 2024
|
23 April 2025
|
| View |
|
DRP-8678-02
|
Clozapine
|
None
|
100 mg
|
Tablet
|
Antipsychotic
|
Sun Pharma Laboratories Limited
|
India
|
CLIDP Conversion
|
20 August 2024
|
23 May 2029
|